QuantBioRes A/S: Financial statements 2022
CVR: 41407352
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
QuantBioRes A/S (CVR 41407352) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -3,770,278 and a net result of DKK -3,065,066 compared with DKK -2,345,335 the year before. Equity in the 2022 report amounted to DKK -6,011,034.
- Gross Profit
- DKK -3,770,278
- Profit/Loss
- DKK -3,065,066
- Equity
- DKK -6,011,034
- Total Assets
- DKK 963,945
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -3.8 mio. | -3.1 mio. | -6 mio. | - |
| 2021 | - | -2.9 mio. | -2.3 mio. | -2.9 mio. | - |
Official annual report
Keep an eye on QuantBioRes A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
QuantBioRes A/S has published its annual report for 2021. Gross profit came to DKK -2,907,012, and the net result was DKK -2,345,335.
About QuantBioRes A/S
QuantBioRes A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Ivan Loncarevic. The board consists of Anthony Slingsby, Mark Andrew Madden and Novak Djokovic. The company is owned by Tulua Doo Beograd - Stari Grad, Anthony Charles Slingsby and Anna Eva Charlotta Slingsby. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,736,412 and a net result of DKK -2,396,479 compared with DKK -1,482,065 the year before. Equity in the 2025 report amounted to DKK 444,094.